Abbott Laboratories Stock Deutsche Boerse AG
Stocks
ABL
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
15:14:13 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 89.31 EUR | +1.10% |
|
-0.45% | -16.25% |
| 01:20pm | Trinity Heart Experts First in the Quad Cities to Use New Afib Technology | CI |
| 09-17 | Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026 | CI |
| Market Cap | 177B 154B 146B 132B 248B 16,974B 249B 1,745B 673B 8,630B 665B 650B 27,768B | P/E 2026 * |
29x | P/E 2027 * | 22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 201B 175B 165B 150B 281B 19,271B 283B 1,981B 764B 9,798B 754B 738B 31,525B | EV / Sales 2026 * |
4x | EV / Sales 2027 * | 3.63x |
| Free-Float |
86.16% | Yield 2026 * |
2.51% | Yield 2027 * | 2.68% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
Xetra
| ABL | Delayed | |
|
CBOE
| Real-time | ||
|
London S.E.
| ABT | Delayed | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Santiago S.E.
| ABT | End-of-day quote | |
|
CBOE
| ABT | Real-time | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | +1.06% | ||
| 1 week | -0.45% | ||
| Current month | -8.61% | ||
| 1 month | -9.00% | ||
| 3 months | +14.46% | ||
| 6 months | -7.13% | ||
| Current year | -16.25% |
| 1 week | 88.02 |  | 89.84 |
| 1 month | 88.02 | | 100.5 |
| Current year | 69.76 | | 109.34 |
| 1 year | 69.76 | | 116.8 |
| 3 years | 69.76 | | 133.78 |
| 5 years | 69.76 | | 133.78 |
| 10 years | 34.46 | | 133.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.11% | -0.45% | - | - | 177B | |
| +0.36% | +0.49% | -23.87% | +1.44% | 177B | |
| -0.31% | +1.75% | -3.18% | +11.78% | 119B | |
| +0.25% | -3.11% | +7.13% | +74.04% | 59.04B | |
| -0.54% | +1.29% | -4.37% | -31.91% | 49.41B | |
| -0.22% | -2.29% | +5.98% | +35.20% | 48.64B | |
| +1.87% | +7.76% | +18.07% | -6.11% | 33.18B | |
| -0.33% | -2.09% | - | - | 28.18B | |
| -1.65% | +4.52% | +41.93% | -8.29% | 25.8B | |
| +1.02% | +5.99% | +7.20% | -19.54% | 21.91B | |
| Average | +0.14% | +1.47% | +6.11% | +7.08% | 62.41B | |
| Weighted average by Cap. | +0.29% | +0.36% | -4.24% | +9.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 43.78B 41.34B 37.54B 70.33B 4,817B 70.62B 495B 191B 2,449B 189B 184B 7,881B | 54.53B 47.55B 44.9B 40.77B 76.39B 5,232B 76.7B 538B 208B 2,660B 205B 200B 8,559B |
| Net income | 6.3B 5.5B 5.19B 4.71B 8.83B 605B 8.87B 62.17B 23.99B 307B 23.68B 23.15B 989B | 7.98B 6.96B 6.57B 5.96B 11.18B 765B 11.22B 78.68B 30.36B 389B 29.97B 29.3B 1,252B |
| Net Debt | 23.94B 20.87B 19.71B 17.9B 33.53B 2,297B 33.67B 236B 91.11B 1,168B 89.93B 87.93B 3,758B | 20.96B 18.27B 17.26B 15.67B 29.36B 2,011B 29.48B 207B 79.76B 1,022B 78.73B 76.98B 3,290B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | €88.36 | +0.02% | 75 |
| 26-09-17 | €88.34 | -1.67% | 250 |
| 26-09-16 | €89.84 | +0.92% | 536 |
| 26-09-15 | €89.02 | -0.51% | 0 |
| 26-09-14 | €89.48 | +0.81% | 27 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABL Stock
Select your edition
All financial news and data tailored to specific country editions
